These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the notion of targeting ACKR3 as a singular solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated disorders. Researchers think that blocking this https://jackr470urm9.wiki-jp.com/user